Prof. dr. J.W. Jukema

Prof. dr. J.W. Jukema

Prof. dr. J.W. (Wouter) Jukema is opgeleid tot cardioloog in Amsterdam (Vrije Universiteit) en Leiden (Leids Universitair Medisch Centrum (LUMC) en is voorzitter van "Leiden Vascular Medicine" en "Established Clinical Investigator" van de Nederlandse Hartstichting. Tevens "founding director" van het in 2007 opgerichte "Durrer Institute for Cardiogenetic Research" in Amsterdam. Zijn promotieonderzoek "angiografic coronary atherosclerosis trials" verrichtte hij voornamelijk op het Interuniversitair Cardiologisch Instituut Nederland (ICIN) in Utrecht.

Zijn onderzoek en dagelijks werkt richt zich met name op athero-trombose, zowel (interventie) cardiologie als coronaire atherosclerose. Deze athero-trombose research focust op vasculaire biologie, lipoproteïnen en genetische achtergronden van athero-trombose en restenose/trombose na PTCA, zowel in mensen als in transgene dieren, en de meerderheid van zijn publicaties hebben dan ook betrekking op deze aandachtsgebieden. Hij is (hoofd)onderzoeker van meerdere internationale athero-trombose studies en lid van een aantal (inter)nationale athero-trombose- en lipiden vergaderingen.  

Top-cited publications

1609 times cited (±96/year) Source: EuropePMC

Lancet (London, England), Volume 360, Issue 9346, 01 November 2002, Pages 1623-1630 Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Abstract


1054 times cited (±126/year) Source: Scopus

Nature genetics, Volume 43, Issue 4, 06 March 2011, Pages 333-338 Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, Preuss M, Stewart AF, Barbalic M, Gieger C, Absher D, Aherrahrou Z, Allayee H, Altshuler D, Anand SS, Andersen K, Anderson JL, Ardissino D, Ball SG, Balmforth AJ, Barnes TA, Becker DM, Becker LC, Berger K, Bis JC, Boekholdt SM, Boerwinkle E, Braund PS, Brown MJ, Burnett MS, Buysschaert I, Cardiogenics, Carlquist JF, Chen L, Cichon S, Codd V, Davies RW, Dedoussis G, Dehghan A, Demissie S, Devaney JM, Diemert P, Do R, Doering A, Eifert S, Mokhtari NE, Ellis SG, Elosua R, Engert JC, Epstein SE, de Faire U, Fischer M, Folsom AR, Freyer J, Gigante B, Girelli D, Gretarsdottir S, Gudnason V, Gulcher JR, Halperin E, Hammond N, Hazen SL, Hofman A, Horne BD, Illig T, Iribarren C, Jones GT, Jukema JW, Kaiser MA, Kaplan LM, Kastelein JJ, Khaw KT, Knowles JW, Kolovou G, Kong A, Laaksonen R, Lambrechts D, Leander K, Lettre G, Li M, Lieb W, Loley C, Lotery AJ, Mannucci PM, Maouche S, Martinelli N, McKeown PP, Meisinger C, Meitinger T, Melander O, Merlini PA Abstract


901 times cited (±96/year) Source: EuropePMC

Lancet (London, England), Volume 375, Issue 9716, 16 February 2010, Pages 735-742 Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I. Abstract


Most recent publications

01 Jul 2019

The lancet. Diabetes & endocrinology, 01 July 2019 Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG, ODYSSEY OUTCOMES Committees and Investigators. Abstract


01 Jul 2019

Nature genetics, Volume 51, Issue 7, 01 July 2019, Pages 1192-1193 Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, Rutten-Jacobs L, Giese AK, van der Laan SW, Gretarsdottir S, Anderson CD, Chong M, Adams HHH, Ago T, Almgren P, Amouyel P, Ay H, Bartz TM, Benavente OR, Bevan S, Boncoraglio GB, Brown RD, Butterworth AS, Carrera C, Carty CL, Chasman DI, Chen WM, Cole JW, Correa A, Cotlarciuc I, Cruchaga C, Danesh J, de Bakker PIW, DeStefano AL, den Hoed M, Duan Q, Engelter ST, Falcone GJ, Gottesman RF, Grewal RP, Gudnason V, Gustafsson S, Haessler J, Harris TB, Hassan A, Havulinna AS, Heckbert SR, Holliday EG, Howard G, Hsu FC, Hyacinth HI, Ikram MA, Ingelsson E, Irvin MR, Jian X, Jiménez-Conde J, Johnson JA, Jukema JW, Kanai M, Keene KL, Kissela BM, Kleindorfer DO, Kooperberg C, Kubo M, Lange LA, Langefeld CD, Langenberg C, Launer LJ, Lee JM, Lemmens R, Leys D, Lewis CM, Lin WY, Lindgren AG, Lorentzen E, Magnusson PK, Maguire J, Manichaikul A, McArdle PF, Meschia JF, Mitchell BD, Mosley TH, Nalls MA, Ninomiya T, O'Donnell MJ, Psaty BM, Pulit SL, Rannikmäe K, Abstract


19 Jun 2019

The American journal of medicine, 19 June 2019 Cognitive Function in Dementia-Free Subjects and Survival in The Old Age: The PROSPER Study. Rostamian S, de Haan S, van der Grond J, van Buchem MA, Ford I, Jukema JW, Sabayan B. Abstract